Long-Term Outcomes After Rituximab Treatment in Patients With Systemic Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis: Follow-up of the DESIRES Trial With a Focus on Serum Immunoglobulin Levels
JAMA Dermatol 2023 Feb 15;[EPub Ahead of Print], A Kuzumi, S Ebata, T Fukasawa, KM Matsuda, H Kotani, A Yoshizaki-Ogawa, S Sato, A YoshizakiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.